FOLH1 and pachyonychia congenita: Accordingly, in patients with cribriform pattern disease detected on initial biopsy or RP, the use of PSMA‐PET may be a valuable adjunct in the staging of primary or BCR PC, specifically regarding the presence of micrometastatic disease in pelvic LN.